P4HA2 is a prognostic marker and exerts oncogenic functions to promote the malignancy of gliomas (grade II to grade IV). The underlying mechanism may be regulating the collagen-dependent PI3K/AKT signaling pathway. This evidence concerns the gene P4HA2 and central nervous system cancer.